Javascript must be enabled to continue!
A Clinical Trial to Evaluate the Efficacy of Topical Application of Modified Vijaya Oil in the Management of Vicharchika (Eczema)
View through CrossRef
Skin disorders have become a major threat in the present era due to the modern lifestyle and stressful living. References to skin diseases in Ayurveda are mostly seen under Kushtha. Vicharchika (Eczema) is one among them with Kapha predominance. The commonly used steroid therapy might lead to side effects. Thus, new topical treatments, such as Modified Vijaya oil, may be useful in reducing the requirement for chronic topical steroid therapy. Aim: To assess the efficacy of topical application of modified Vijaya oil in the management of Vicharchika (Eczema). Materials and Methods: An open-label clinical trial was conducted on 40 patients clinically diagnosed with Vicharchika (Eczema) and the oil was given for topical application for 30 days. The efficacy was evaluated in terms of changes in parameters like EASI (Eczema Area Severity Index), SCORAD (Scoring of Atopic Dermatitis), VAS (Visual Analogue Scale), and SIGA (Static Investigator Global Assessment) before and after the intervention, between Day 0 and 30. The data were collected and analyzed with Wilcoxon Test. Results: The topical application of modified Vijaya oil was found to be highly effective in reducing the symptoms of Vicharchika (Eczema). Conclusion: Modified Vijaya oil could be used in symptomatic relief of Vicharchika (Eczema), and also repairs and enhances the damaged skin.
Title: A Clinical Trial to Evaluate the Efficacy of Topical Application of Modified Vijaya Oil in the Management of Vicharchika (Eczema)
Description:
Skin disorders have become a major threat in the present era due to the modern lifestyle and stressful living.
References to skin diseases in Ayurveda are mostly seen under Kushtha.
Vicharchika (Eczema) is one among them with Kapha predominance.
The commonly used steroid therapy might lead to side effects.
Thus, new topical treatments, such as Modified Vijaya oil, may be useful in reducing the requirement for chronic topical steroid therapy.
Aim: To assess the efficacy of topical application of modified Vijaya oil in the management of Vicharchika (Eczema).
Materials and Methods: An open-label clinical trial was conducted on 40 patients clinically diagnosed with Vicharchika (Eczema) and the oil was given for topical application for 30 days.
The efficacy was evaluated in terms of changes in parameters like EASI (Eczema Area Severity Index), SCORAD (Scoring of Atopic Dermatitis), VAS (Visual Analogue Scale), and SIGA (Static Investigator Global Assessment) before and after the intervention, between Day 0 and 30.
The data were collected and analyzed with Wilcoxon Test.
Results: The topical application of modified Vijaya oil was found to be highly effective in reducing the symptoms of Vicharchika (Eczema).
Conclusion: Modified Vijaya oil could be used in symptomatic relief of Vicharchika (Eczema), and also repairs and enhances the damaged skin.
Related Results
To Assess the Efficacy of Japapatryadi Tail and Amritadi Kwath in Vicharchika (Eczema)
To Assess the Efficacy of Japapatryadi Tail and Amritadi Kwath in Vicharchika (Eczema)
Skin disorders are increasingly prevalent today due to modern lifestyles and stress. Ayurveda references skin diseases primarily under the category of Kushtha, with Vicharchika (ec...
Clinical evaluation of the efficacy of Vajraka ghrita in management of Vicharchika (atopic dermatitis/eczema) – A single arm clinical study
Clinical evaluation of the efficacy of Vajraka ghrita in management of Vicharchika (atopic dermatitis/eczema) – A single arm clinical study
Background: Ayurveda, an ancient medical science, offers profound insights into skin health through its understanding of "Kushtha," a term encompassing various skin ailments. Ayurv...
SUCCESSFUL AYURVEDIC MANAGEMENT OF VICHARCHIKA (ECZEMA) - A CASE STUDY
SUCCESSFUL AYURVEDIC MANAGEMENT OF VICHARCHIKA (ECZEMA) - A CASE STUDY
Vicharchika is skin lesions of varying size with inflammation, severe itching sensation, with bleeding in some cases, and this condition is as distressing as it causes disfiguremen...
Clinical Evaluation of Ayurvedic Treatment in Chronic Lichenified Eczema (Vicharchika): A Case Report
Clinical Evaluation of Ayurvedic Treatment in Chronic Lichenified Eczema (Vicharchika): A Case Report
Introduction: Chronic Lichenified Eczema, also known as Lichen Simplex Chronicus, is a chronic inflammatory skin disorder characterized by persistent itching, lichenification, hype...
Effect of Virechana Karma Along with Japapatryadi Tail Local Application and Amritadi Kwath Orally in the Management of Vicharchika
Effect of Virechana Karma Along with Japapatryadi Tail Local Application and Amritadi Kwath Orally in the Management of Vicharchika
In the present case report, a 58-year-old man consulted in the Outpatient department of Dayanand Ayurvedic College, Jalandhar. The complaint of the patient was recurrent skin rashe...
Clinical evaluation of Amrita Ghrita Sneha-Pana followed by Pippalyadi Yoga Virechana in the management of Vicharchika (chronic dermatitis)
Clinical evaluation of Amrita Ghrita Sneha-Pana followed by Pippalyadi Yoga Virechana in the management of Vicharchika (chronic dermatitis)
Background: Vicharchika is a Kapha dominated Tridoshaja Kshudra Kustha (minor skin disease) primarily characterized by eruptions with hyperpigmentation, itching and profuse dischar...
Role of Virechana Karma in the Management of Vicharchika w.s.r. to Eczema - A Case Study
Role of Virechana Karma in the Management of Vicharchika w.s.r. to Eczema - A Case Study
The bulk of skin conditions are seen in Ayurveda as being within the category of Kushtha, or "Ayurvedic dermatology." It is listed as among the “Ashta Mahagada”. Eczema is the most...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

